| Mar 4, 2026 |
Mar 6, 2026 |
Morris Shannon
|
Chief Medical Officer |
Sell |
10.0
|
-20,000
|
-100.00%
|
✓
|
$300.8K |
| Jan 29, 2026 |
Jan 30, 2026 |
Lim Jonathan E
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 15, 2025 |
Jan 30, 2026 |
Chacko David M.
|
CFO |
Buy |
86.3
|
+17,793
|
6.79%
|
✗
|
$21.3K |
| Jan 29, 2026 |
Jan 30, 2026 |
Morris Shannon
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 29, 2026 |
Jan 30, 2026 |
Varney Michael David
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 29, 2026 |
Jan 30, 2026 |
Garner Ebun
|
General Counsel & Corp. Sec. |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 15, 2025 |
Jan 8, 2026 |
Garner Ebun
|
General Counsel & Corp. Sec. |
Sell |
10.0
|
-116,098
|
-69.83%
|
✓
|
$670.8K |
| Jan 1, 2026 |
Jan 5, 2026 |
Bristol James Arthur
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 1, 2026 |
Jan 5, 2026 |
LIU JEAN I
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 1, 2026 |
Jan 5, 2026 |
Multani Pratik S
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 1, 2026 |
Jan 5, 2026 |
Start Valerie Denise Harding
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 1, 2026 |
Jan 5, 2026 |
Casdin Alexander W.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 24, 2025 |
Jun 26, 2025 |
Varney Michael David
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 24, 2025 |
Jun 26, 2025 |
LIU JEAN I
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 24, 2025 |
Jun 26, 2025 |
Hambleton Julie
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 24, 2025 |
Jun 26, 2025 |
Start Valerie Denise Harding
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 24, 2025 |
Jun 26, 2025 |
Multani Pratik S
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 24, 2025 |
Jun 26, 2025 |
Bristol James Arthur
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 24, 2025 |
Jun 26, 2025 |
Casdin Alexander W.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 23, 2025 |
Jun 3, 2025 |
Multani Pratik S
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 13, 2025 |
Feb 18, 2025 |
Garner Ebun
|
General Counsel & Corp. Sec. |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 14, 2024 |
Feb 5, 2025 |
Chacko David M.
|
CFO |
Buy |
83.8
|
+15,461
|
3.04%
|
✗
|
$24.2K |
| Feb 3, 2025 |
Feb 5, 2025 |
Morris Shannon
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 14, 2024 |
Feb 5, 2025 |
Garner Ebun
|
General Counsel & Corp. Sec. |
Buy |
91.3
|
+11,446
|
37.04%
|
✗
|
$17.9K |
| Feb 3, 2025 |
Feb 5, 2025 |
Lim Jonathan E
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 1, 2025 |
Jan 2, 2025 |
Casdin Alexander W.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 1, 2025 |
Jan 2, 2025 |
LIU JEAN I
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 1, 2025 |
Jan 2, 2025 |
Start Valerie Denise Harding
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 1, 2025 |
Jan 2, 2025 |
Bristol James Arthur
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 20, 2024 |
Jun 21, 2024 |
Varney Michael David
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 20, 2024 |
Jun 21, 2024 |
Start Valerie Denise Harding
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 20, 2024 |
Jun 21, 2024 |
LIU JEAN I
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 20, 2024 |
Jun 21, 2024 |
Garner Ebun
|
General Counsel & Corp. Sec. |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 20, 2024 |
Jun 21, 2024 |
Morris Shannon
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 20, 2024 |
Jun 21, 2024 |
Lim Jonathan E
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 20, 2024 |
Jun 21, 2024 |
Chacko David M.
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 20, 2024 |
Jun 21, 2024 |
Hambleton Julie
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 20, 2024 |
Jun 21, 2024 |
Casdin Alexander W.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 20, 2024 |
Jun 21, 2024 |
Bristol James Arthur
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 20, 2024 |
Jun 21, 2024 |
Multani Pratik S
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 21, 2024 |
May 22, 2024 |
Casdin Alexander W.
|
Director |
Buy |
95.0
|
+80,000
|
13.61%
|
✗
|
$181.9K |
| Feb 5, 2024 |
Feb 7, 2024 |
Lim Jonathan E
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 5, 2024 |
Feb 7, 2024 |
Chacko David M.
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 5, 2024 |
Feb 7, 2024 |
Garner Ebun
|
General Counsel & Corp. Sec. |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 5, 2024 |
Feb 7, 2024 |
Morris Shannon
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 1, 2024 |
Jan 3, 2024 |
Bristol James Arthur
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 1, 2024 |
Jan 3, 2024 |
Multani Pratik S
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 1, 2024 |
Jan 3, 2024 |
LIU JEAN I
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 1, 2024 |
Jan 3, 2024 |
Start Valerie Denise Harding
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 1, 2024 |
Jan 3, 2024 |
Casdin Alexander W.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 15, 2023 |
Dec 18, 2023 |
Chacko David M.
|
CFO |
Buy |
83.8
|
+7,478
|
3.13%
|
✗
|
$11.9K |
| Dec 15, 2023 |
Dec 18, 2023 |
Garner Ebun
|
General Counsel & Corp. Sec. |
Buy |
90.0
|
+5,448
|
127.29%
|
✗
|
$8.7K |
| Dec 6, 2023 |
Dec 8, 2023 |
Start Valerie Denise Harding
|
Director |
Buy |
91.3
|
+10,000
|
83.33%
|
✗
|
$18.5K |
| Dec 5, 2023 |
Dec 6, 2023 |
Lim Jonathan E
|
CEO |
Buy |
87.5
|
+1,000,000
|
2.26%
|
✗
|
$1.7M |
| Dec 4, 2023 |
Dec 4, 2023 |
Casdin Alexander W.
|
Director |
Buy |
86.3
|
+30,000
|
5.38%
|
✗
|
$49.8K |
| Oct 5, 2023 |
Oct 10, 2023 |
Lim Jonathan E
|
CEO |
Buy |
92.5
|
+1,000,000
|
3.29%
|
✗
|
$2M |
| Jun 22, 2023 |
Jun 26, 2023 |
Chen Bihua
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 22, 2023 |
Jun 26, 2023 |
Varney Michael David
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 22, 2023 |
Jun 26, 2023 |
Multani Pratik S
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 22, 2023 |
Jun 26, 2023 |
LIU JEAN I
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jun 26, 2023 |
Lim Jonathan E
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 22, 2023 |
Jun 26, 2023 |
Start Valerie Denise Harding
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 22, 2023 |
Jun 26, 2023 |
Hambleton Julie
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 22, 2023 |
Jun 26, 2023 |
Casdin Alexander W.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 22, 2023 |
Jun 26, 2023 |
Bristol James Arthur
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 8, 2023 |
Jun 8, 2023 |
Lim Jonathan E
|
CEO |
Buy |
67.5
|
+100,000
|
0.33%
|
✗
|
$275K |
| Apr 10, 2023 |
Apr 13, 2023 |
Morris Shannon
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Apr 13, 2023 |
Morris Shannon
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 10, 2023 |
Apr 11, 2023 |
Casdin Alexander W.
|
Director |
Buy |
87.5
|
+20,000
|
3.72%
|
✗
|
$55.2K |
| Mar 28, 2023 |
Mar 28, 2023 |
Lim Jonathan E
|
CEO |
Buy |
67.5
|
+100,000
|
0.33%
|
✗
|
$284K |
| Nov 30, 2022 |
Feb 15, 2023 |
Lim Jonathan E
|
CEO |
Neutral |
27.5
|
-2,000,006
|
-6.23%
|
✗
|
- |
| Feb 1, 2023 |
Feb 3, 2023 |
Lim Jonathan E
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 1, 2023 |
Feb 3, 2023 |
Chacko David M.
|
CFO |
Buy |
60.0
|
+1,750
|
0.37%
|
✗
|
$7.2K |
| Feb 1, 2023 |
Feb 3, 2023 |
Wei Lin
|
Chief Medical Officer |
Buy |
60.0
|
+1,750
|
0.28%
|
✗
|
$7.2K |
| Feb 1, 2023 |
Feb 3, 2023 |
Garner Ebun
|
General Counsel & Corp. Sec. |
Buy |
90.0
|
+2,390
|
38.74%
|
✗
|
$9.8K |
| Jan 10, 2023 |
Jan 10, 2023 |
Lim Jonathan E
|
CEO |
Buy |
60.0
|
+60,000
|
0.19%
|
✗
|
$231.4K |
| Dec 21, 2022 |
Dec 22, 2022 |
Start Valerie Denise Harding
|
Director |
Buy |
91.3
|
+10,000
|
500.00%
|
✗
|
$46.4K |
| Dec 21, 2022 |
Dec 22, 2022 |
Bristol James Arthur
|
Director |
Buy |
95.0
|
+20,000
|
10.67%
|
✗
|
$82.8K |
| Dec 13, 2022 |
Dec 21, 2022 |
Chen Bihua
|
Director |
Buy |
92.5
|
+307,692
|
2.93%
|
✗
|
$2M |
| Dec 13, 2022 |
Dec 20, 2022 |
Chen Bihua
|
Director |
Buy |
92.5
|
+307,692
|
2.93%
|
✗
|
$2M |
| Dec 15, 2022 |
Dec 15, 2022 |
Casdin Alexander W.
|
Director |
Buy |
87.5
|
+20,000
|
3.86%
|
✗
|
$97.5K |
| Dec 14, 2022 |
Dec 15, 2022 |
Lim Jonathan E
|
CEO |
Buy |
60.0
|
+40,000
|
0.12%
|
✗
|
$199.6K |
| Jul 1, 2022 |
Jul 6, 2022 |
Casdin Alexander W.
|
Director |
Neutral |
27.5
|
-750,000
|
-59.16%
|
✗
|
- |
| Jun 22, 2022 |
Jun 24, 2022 |
Chen Bihua
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 22, 2022 |
Jun 24, 2022 |
Varney Michael David
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 22, 2022 |
Jun 24, 2022 |
Multani Pratik S
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 22, 2022 |
Jun 24, 2022 |
Start Valerie Denise Harding
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 22, 2022 |
Jun 24, 2022 |
Hambleton Julie
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 22, 2022 |
Jun 24, 2022 |
Casdin Alexander W.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 22, 2022 |
Jun 24, 2022 |
Bristol James Arthur
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 25, 2022 |
Apr 27, 2022 |
LIU JEAN I
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Apr 27, 2022 |
LIU JEAN I
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 1, 2022 |
Feb 3, 2022 |
Garner Ebun
|
General Counsel & Corp. Sec. |
Buy |
91.3
|
+990
|
110.00%
|
✗
|
$11.5K |
| Feb 1, 2022 |
Feb 3, 2022 |
Wei Lin
|
Chief Medical Officer |
Buy |
61.3
|
+1,562
|
0.50%
|
✗
|
$18.1K |
| Feb 1, 2022 |
Feb 3, 2022 |
Lim Jonathan E
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 1, 2022 |
Feb 3, 2022 |
Chacko David M.
|
CFO |
Buy |
68.8
|
+1,562
|
0.66%
|
✗
|
$18.1K |
| Jul 26, 2021 |
Aug 10, 2021 |
Chen Bihua
|
Director |
Buy |
45.0
|
-
|
0.00%
|
✗
|
$667K |
| Jul 20, 2021 |
Jul 22, 2021 |
Chen Bihua
|
Director |
Buy |
97.5
|
+950,000
|
9.94%
|
✗
|
$15.2M |
| Jul 20, 2021 |
Jul 20, 2021 |
Lim Jonathan E
|
Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 20, 2021 |
Jul 20, 2021 |
Garner Ebun
|
General Counsel |
Buy |
91.3
|
+900
|
100.00%
|
✗
|
$14.4K |